Physician

Long Hoang Dang, MD, PHD

According to 2025 Medicare claims, Long Dang, MD, PHD (NPI: 1528144581) practices hematology/oncology in the Palm Bay-Melbourne-Titusville, FL market, with the plurality of this provider's patient population coming from Brevard, FL. This provider's primary affiliated billing organization is HEALTH FIRST MEDICAL GROUP, LLC (NPI: 1750626495; TIN: 461243081) and primary practice location at 32940-2240. Dang is affiliated with the Ochsner Accountable Care Network, LLC (ACO ID: A1535) and Privia Quality Network Central Florida, LLC (ACO ID: A4947), participating under the MSSP model.

Dang's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,275 traditional Medicare patients, billed 336,639 HCPCS/CPT codes, and received $4,938,985 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 2,049 prescription claims across 326 beneficiaries totaling $4,499,109 in drug costs, led by Xtandi (Enzalutamide). 2023 DME data shows 17 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $131,624 to $4,938,985. Similarly, Part D prescription costs have risen steadily, from $1,295,600 to $4,499,109. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $12,363 to $368.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$2.5M$4.9M2015 Medicare payment: $131,624 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $120,050 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $133,023 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $99,606 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $76,400 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $58,924 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $2,497,461 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $3,384,146 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $4,337,468 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $4,938,985 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20155141,670$131,624
20165401,826$120,050
20175511,924$133,023
20184681,463$99,606
2019297943$76,400
2020271854$58,924
2021671164,538$2,497,461
2022974219,315$3,384,146
20231,161295,960$4,337,468
20241,275336,639$4,938,985

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$2.2M$4.5M2015 Drug cost: $1,295,600 (USD; Tot_Drug_Cst)2016 Drug cost: $1,744,552 (USD; Tot_Drug_Cst)2017 Drug cost: $1,795,782 (USD; Tot_Drug_Cst)2018 Drug cost: $3,697,337 (USD; Tot_Drug_Cst)2019 Drug cost: $2,043,350 (USD; Tot_Drug_Cst)2020 Drug cost: $2,953,064 (USD; Tot_Drug_Cst)2021 Drug cost: $1,209,196 (USD; Tot_Drug_Cst)2022 Drug cost: $1,958,757 (USD; Tot_Drug_Cst)2023 Drug cost: $3,983,619 (USD; Tot_Drug_Cst)2024 Drug cost: $4,499,109 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20151801,218$1,295,600
20161671,144$1,744,552
20172281,359$1,795,782
20182011,278$3,697,337
20193141,617$2,043,350
20203042,546$2,953,064
20212011,036$1,209,196
20222061,348$1,958,757
20232692,028$3,983,619
20243262,049$4,499,109

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$19K$38K2015 Medicare payment: $37,539 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $6,545 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $3,846 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $5,874 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $710 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $3,825 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $7,192 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
201573302$37,539
2016N/R131$6,545
2017N/R122$3,846
2018N/R168$5,874
2019N/R48$710
2020N/RN/RN/R
2021N/RN/RN/R
2022N/R46$3,825
2023N/R17$7,192
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99215Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more228888$132
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more5091,081$91
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more289357$62
96365Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less197429$45
96372Injection of drug or substance under skin or into muscle210637$10

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
XtandiEnzalutamide561,680$670,142
PomalystPomalidomide27756$604,730
KisqaliRibociclib Succinate26728$390,129
BrukinsaZanubrutinib29870$263,040
VerzenioAbemaciclib17476$242,856

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

FAQ

What Medicare data is available for Long Hoang Dang, MD, PHD?

Tedicare shows public-source Medicare data for Long Hoang Dang, MD, PHD (NPI 1528144581), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Long Hoang Dang, MD, PHD have ACO affiliation data?

Long Hoang Dang, MD, PHD is shown with ACO affiliation data for Ochsner Accountable Care Network, LLC (MSSP, ACO ID A1535) and Privia Quality Network Central Florida, LLC (MSSP, ACO ID A4947).

What billing organization is linked to Long Hoang Dang, MD, PHD?

Long Hoang Dang, MD, PHD is linked to HEALTH FIRST MEDICAL GROUP, LLC (billing NPI 1750626495) in the available physician profile data.

Does Long Hoang Dang, MD, PHD have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.